Location: Luxembourg
CIK: 0001053906 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 13, 2026
Total Value: $931M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 175,156,062 (+13.2%) | $420M (+74.2%) | 45.1% | $3.53 | — | COM NEW | 528872302 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CAVA | Cava Group Inc | 6,507,990 (-31.6%) | $511M (-33.6%) | 54.9% | $41.17 | — | COM | 148929102 |